| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Characterisation of rare haematological immune-related toxicities
|
Haanen, John B
|
|
2019
|
6 |
1 |
p. e10-e11
|
artikel
|
| 2 |
Closing in on targeted therapy for acute myeloid leukaemia
|
The Lancet Haematology,
|
|
2019
|
6 |
1 |
p. e1
|
artikel
|
| 3 |
Concurrent treatment with two B-cell receptor pathway inhibitors
|
Robak, Tadeusz
|
|
2019
|
6 |
1 |
p. e8-e9
|
artikel
|
| 4 |
10-day decitabine schedule in acute myeloid leukaemia: no extra bang for the buck
|
Cashen, Amanda F
|
|
2019
|
6 |
1 |
p. e6-e7
|
artikel
|
| 5 |
Effectiveness and safety of apixaban versus rivaroxaban for prevention of recurrent venous thromboembolism and adverse bleeding events in patients with venous thromboembolism: a retrospective population-based cohort analysis
|
Dawwas, Ghadeer K
|
|
2019
|
6 |
1 |
p. e20-e28
|
artikel
|
| 6 |
Haematological immune-related adverse events induced by anti-PD-1 or anti-PD-L1 immunotherapy: a descriptive observational study
|
Delanoy, Nicolas
|
|
2019
|
6 |
1 |
p. e48-e57
|
artikel
|
| 7 |
Safety and activity of sintilimab in patients with relapsed or refractory classical Hodgkin lymphoma (ORIENT-1): a multicentre, single-arm, phase 2 trial
|
Shi, Yuankai
|
|
2019
|
6 |
1 |
p. e12-e19
|
artikel
|
| 8 |
Sintilimab: another effective immune checkpoint inhibitor in classical Hodgkin lymphoma
|
Ansell, Stephen M
|
|
2019
|
6 |
1 |
p. e2-e3
|
artikel
|
| 9 |
The best direct-acting oral anticoagulant for treatment of venous thromboembolism?
|
Frere, Corinne
|
|
2019
|
6 |
1 |
p. e4-e5
|
artikel
|
| 10 |
Treatment with a 5-day versus a 10-day schedule of decitabine in older patients with newly diagnosed acute myeloid leukaemia: a randomised phase 2 trial
|
Short, Nicholas J
|
|
2019
|
6 |
1 |
p. e29-e37
|
artikel
|
| 11 |
Umbralisib in combination with ibrutinib in patients with relapsed or refractory chronic lymphocytic leukaemia or mantle cell lymphoma: a multicentre phase 1–1b study
|
Davids, Matthew S
|
|
2019
|
6 |
1 |
p. e38-e47
|
artikel
|
Tijdschrift beschrijving